We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current FBLG market cap is 88.07M. The company's latest EPS is USD -0.5420 and P/E is -4.61.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -2.05M | -2.48M | -3.45M | -3.22M |
Net Income | -2.19M | -12.29M | -8.46M | 898k |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -4.47M | -8.89M |
Net Income | -5.12M | -19.06M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Total Assets | 13.3M | 11.82M | 11.4M | 8.91M |
Total Liabilities | 2.76M | 10.57M | 15.26M | 11.3M |
Total Equity | 10.54M | 1.25M | -3.86M | -2.39M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 4.82M | 11.82M |
Total Liabilities | 8.82M | 10.57M |
Total Equity | -4M | 1.25M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | |||
Operating | -4.8M | -6.4M | -4.28M | -6.22M |
Investing | -493k | -495k | -8k | -74k |
Financing | 13.79M | 13.79M | 3.28M | 3.11M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -4.07M | -6.4M |
Investing | N/A | -495k |
Financing | 5.93M | 13.79M |
Market Cap | 88.07M |
Price to Earnings Ratio | -4.61 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.59 |
Price to Book Ratio | 70.15 |
Dividend Yield | - |
Shares Outstanding | 35.16M |
Average Volume (1 week) | 197.98k |
Average Volume (1 Month) | 188.11k |
52 Week Change | -91.65% |
52 Week High | 55.00 |
52 Week Low | 1.0779 |
Spread (Intraday) | 0.93 (28.35%) |
Company Name | FibroBiologics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.fibrobiologics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions